参麦注射液对合并心源性休克的急性心肌梗死的疗效观察
Journal: Frontier Forum of Clinical Medicine DOI: 10.12238/ffcr.v3i1.12598
Abstract
目的：探究参麦注射液对合并心源性休克的急性心肌梗死患者心脏功能的影响及其疗效分析。方法：选取2023年1月1日至2024年1月1日诸暨市人民医院心血管内科收治的60例合并心源性休克的急性心肌梗死患者为研究对象。根据治疗方案不同将其平均分为两组：对照组和实验组。对照组给予常规西药治疗,实验组在常规治疗的基础上加用参麦注射液治疗。比较治疗前后两组患者在血压、心肌钙蛋白、心脏功能等方面的差异。结果：对照组和实验组患者在一般临床资料上无明显差异。药物治疗后,实验组患者血压水平较对照组显著上升,实验组患者肌钙蛋白、CK-MB较对照组显著降低,实验组患者心脏功能较对照组显著改善。结论：常规治疗联合参麦注射液可改善合并心源性休克的急性心肌梗死患者的血压水平和心脏功能,从而减少由于心肌梗死引起的心肌损伤。
Keywords
参麦注射液；急性心肌梗死；心源性休克
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Shah AH, Puri R, Kalra A. Management of cardiogenic shock complicating acute myocardial infarction: A review. Clin Cardiol.2019;42(4):484-493.
[2] Liakos M, Parikh PB. Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction. Curr Cardiol Rep.2018;20(8):64.
[3] Khalili H, Banerjee S, Brilakis ES. Arteria Lusoria in a Patient With ST-Segment Elevation Acute Myocardial Infar ction: Implications for Primary PCI. J Invasive Cardiol. 2015;27(6):E106.
[4] Di Vece D,Citro R,Cammann VL,et al.Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. Circulation. 2019;139(3):413-415.
[5] Thiele H, Akin I, Sandri M, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.N Engl J Med.2017;377(25):2419-2432.
[6] Wu Y, Li T, Li P, et al. Effects of Shenmai injection against chronic heart failure: a meta-analysis and systematic review of preclinical and clinical studies. Front Pharmacol. 2024;14:1338975.
[7] 杨震.急性心肌梗死合并心源性休克的诊断及治疗进展[J].心血管病学进展,2012,33(6):763-767.
[8] Vasatova M, Pudil R, Tichy M, et al. High-sensitivity troponin T as a marker of myocardial injury after radiofre quency catheter ablation. Ann Clin Biochem.2011;48(Pt 1):38-40.
[9] 张不凡,张宇辉,刘彤.射血分数中间值心力衰竭研究新进展[J].中国心血管病研究,2019,17(4):294-299.
[10] Chen L,Wang L,Zhuo Q,et al.Effect of Shenmai inject ion on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial. BMC Anesthesiol.2018;18(1):142.
[11] 石建,李世峰.参麦注射液辅助治疗急性心肌梗死的临床研究[J].中国临床药理学杂志,2016,32(24):15.
[12] 李佳,阮琳,李琳.参麦注射液对急性下壁心肌梗死并发症的影响[J].长春中医药大学学报,2018,34(2):11
[13] 赵燕,张毅刚,王海波.参麦注射液治疗急性心肌梗死相关心力衰竭105例[J].河南中医,2016,36(10):17.
[2] Liakos M, Parikh PB. Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction. Curr Cardiol Rep.2018;20(8):64.
[3] Khalili H, Banerjee S, Brilakis ES. Arteria Lusoria in a Patient With ST-Segment Elevation Acute Myocardial Infar ction: Implications for Primary PCI. J Invasive Cardiol. 2015;27(6):E106.
[4] Di Vece D,Citro R,Cammann VL,et al.Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. Circulation. 2019;139(3):413-415.
[5] Thiele H, Akin I, Sandri M, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.N Engl J Med.2017;377(25):2419-2432.
[6] Wu Y, Li T, Li P, et al. Effects of Shenmai injection against chronic heart failure: a meta-analysis and systematic review of preclinical and clinical studies. Front Pharmacol. 2024;14:1338975.
[7] 杨震.急性心肌梗死合并心源性休克的诊断及治疗进展[J].心血管病学进展,2012,33(6):763-767.
[8] Vasatova M, Pudil R, Tichy M, et al. High-sensitivity troponin T as a marker of myocardial injury after radiofre quency catheter ablation. Ann Clin Biochem.2011;48(Pt 1):38-40.
[9] 张不凡,张宇辉,刘彤.射血分数中间值心力衰竭研究新进展[J].中国心血管病研究,2019,17(4):294-299.
[10] Chen L,Wang L,Zhuo Q,et al.Effect of Shenmai inject ion on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial. BMC Anesthesiol.2018;18(1):142.
[11] 石建,李世峰.参麦注射液辅助治疗急性心肌梗死的临床研究[J].中国临床药理学杂志,2016,32(24):15.
[12] 李佳,阮琳,李琳.参麦注射液对急性下壁心肌梗死并发症的影响[J].长春中医药大学学报,2018,34(2):11
[13] 赵燕,张毅刚,王海波.参麦注射液治疗急性心肌梗死相关心力衰竭105例[J].河南中医,2016,36(10):17.
Copyright © 2025 詹嘉琛, 张顺顺, 陈天枫
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
